More MS news articles for Jan 2002

Enhanced Expression of NGF Receptors in Multiple Sclerosis Lesions

Journal of Neuropathology and Experimental Neurology: Vol. 61, No. 1, pp. 9198.
Paola Valdo, PhD, Chiara Stegagno, MD, Sara Mazzucco, MD, Elisa Zuliani, GianLuigi Zanusso, MD, PhD, Giuseppe Moretto, MD, Cedric S. Raine, PhD, DSc, FRCPath, and Bruno Bonetti, MD, PhD


The receptor for nerve growth factor (NGF) comprises a 75-kDa (NGFRp75) and a tyrosine kinase A (TrkA) subunit.

In view of conflicting opinions on the identity of glial targets of NGF in human central nervous system (CNS), we examined the cellular distribution of both NGF receptor subunits in normal CNS and in chronic multiple sclerosis (MS) lesions.

For this, we compared the pattern of recognition of 2 monoclonal antibodies (mAbs) and a polyclonal antiserum to NGFRp75.

Only the 2 mAbs specifically recognized NGFRp75, while the polyclonal antiserum showed widespread reactivity.

In normal CNS and silent MS lesions, immunohistochemistry with anti-NGFRp75 mAbs and for TrkA revealed perivascular cell reactivity.

At the edge of chronic active MS lesions, selective NGFRp75 staining was prominent on reactive astrocytes, while throughout the lesion, NGFRp75 was expressed on microglia/macrophages.

The vast majority of mature or precursor oligodendrocytes did not express NGFRp75.

Both NGF receptors were co-expressed on a subset of inflammatory cells.

Immunoreactivity for NGFRp75 on glial and immune cells did not correlate with the distribution of apoptotic figures, as detected by TUNEL.

Thus, expression of NGF receptors in active MS lesions suggests a role for NGF in regulating the autoimmune response at both immune and glial cell levels.

© Copyright by American Association of Neuropathologists, Inc. 2002